BPIFC

gene
On this page

Also known as dJ149A16.7

Summary

BPIFC (BPI fold containing family C, HGNC:16503) is a protein-coding gene on chromosome 22q12.3, encoding BPI fold-containing family C protein (Q8NFQ6).

Predicted to enable lipopolysaccharide binding activity and phospholipid binding activity. Predicted to be involved in defense response to Gram-negative bacterium and innate immune response. Predicted to be located in extracellular region. Predicted to be active in extracellular space.

Source: NCBI Gene 254240 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): trichilemmal cyst (Limited, GenCC)
  • GWAS associations: 1
  • Clinical variants (ClinVar): 76 total
  • MANE Select transcript: NM_174932

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:16503
Approved symbolBPIFC
NameBPI fold containing family C
Location22q12.3
Locus typegene with protein product
StatusApproved
AliasesdJ149A16.7
Ensembl geneENSG00000184459
Ensembl biotypeprotein_coding
OMIM614109
Entrez254240

Gene structure

Transcript identifiers

Ensembl transcripts: 4 — 3 protein_coding, 1 nonsense_mediated_decay

ENST00000300399, ENST00000397450, ENST00000397452, ENST00000534972

RefSeq mRNA: 1 — MANE Select: NM_174932 NM_174932

CCDS: CCDS13906

Canonical transcript exons

ENST00000300399 — 17 exons

ExonStartEnd
ENSE000011094303243237332432543
ENSE000011094323241936232419404
ENSE000011094333243134732431414
ENSE000013085903241708532417148
ENSE000013159503241591532415991
ENSE000013242453243371932433772
ENSE000015287183246157432461661
ENSE000034971263244584132445996
ENSE000036061923245338332453503
ENSE000036881123244563532445698
ENSE000036913643244721232447340
ENSE000037160643244267132442731
ENSE000037191593243776032437851
ENSE000037213703243570432435880
ENSE000037579553245726332457386
ENSE000039271193241384532414425
ENSE000039384213246437432464446

Expression profiles

Bgee: expression breadth broad, 79 present calls, max score 95.14.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0668 / max 18.3021, expressed in 21 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1937480.066821

Top tissues by expression

213 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
upper leg skinUBERON:000426295.14gold quality
skin of abdomenUBERON:000141691.32gold quality
zone of skinUBERON:000001490.86gold quality
skin of legUBERON:000151190.32gold quality
mammalian vulvaUBERON:000099788.78gold quality
skin of hipUBERON:000155488.29gold quality
gingival epitheliumUBERON:000194986.51gold quality
gingivaUBERON:000182886.42gold quality
penisUBERON:000098984.89gold quality
spermCL:000001984.00silver quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047381.48gold quality
nippleUBERON:000203079.19gold quality
islet of LangerhansUBERON:000000678.77gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099166.91gold quality
body of tongueUBERON:001187663.77silver quality
tongueUBERON:000172359.16silver quality
skeletal muscle tissue of biceps brachiiUBERON:000450258.88gold quality
lateral globus pallidusUBERON:000247657.46gold quality
left testisUBERON:000453355.94gold quality
right testisUBERON:000453455.84gold quality
lateral nuclear group of thalamusUBERON:000273655.42gold quality
testisUBERON:000047355.30gold quality
substantia nigra pars reticulataUBERON:000196654.89gold quality
pharyngeal mucosaUBERON:000035553.68gold quality
superior surface of tongueUBERON:000737153.63gold quality
buccal mucosa cellCL:000233653.51gold quality
dorsal plus ventral thalamusUBERON:000189753.04gold quality
ventral tegmental areaUBERON:000269152.86gold quality
subthalamic nucleusUBERON:000190652.82gold quality
layer of synovial tissueUBERON:000761652.02gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.41

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

41 targeting BPIFC, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3163100.0077.238605
HSA-MIR-513B-5P99.9969.962150
HSA-MIR-480399.9871.993117
HSA-MIR-23B-5P99.9866.07587
HSA-MIR-570-3P99.9672.414910
HSA-MIR-495-3P99.9672.814197
HSA-MIR-568899.9673.234504
HSA-MIR-548AA99.9670.643753
HSA-MIR-548AP-3P99.9670.643753
HSA-MIR-548T-3P99.9670.643753
HSA-MIR-6783-3P99.8967.922059
HSA-MIR-1343-3P99.8966.781815
HSA-MIR-204-5P99.7971.622439
HSA-MIR-211-5P99.7971.652440
HSA-MIR-10393-3P99.7266.56961
HSA-MIR-6801-5P99.7266.50981
HSA-MIR-4755-5P99.7170.342716
HSA-MIR-5006-3P99.7170.262728
HSA-MIR-80299.6167.701254
HSA-MIR-199A-5P99.5169.711107
HSA-MIR-199B-5P99.5169.741098
HSA-MIR-6852-5P99.1766.692073
HSA-MIR-323B-3P99.1468.89725
HSA-MIR-6738-3P99.0367.141326
HSA-MIR-5001-3P98.9167.281394
HSA-MIR-181A-2-3P98.9167.601168
HSA-MIR-629-5P98.7868.721032
HSA-MIR-6776-5P98.5467.431304
HSA-MIR-4720-3P98.5068.88988
HSA-MIR-499B-5P98.3568.39988

Literature-anchored findings (GeneRIF, showing 3)

  • BPIL2maps to Chr 22q13. AA sequence is reported. (PMID:12185532)
  • BPIFC c.3G>C mutation segregates with hereditary trichilemmal cysts in a large Chinese family. (PMID:31033252)
  • Transcriptomic Analyses and Experimental Validation Identified Immune-Related lncRNA-mRNA Pair MIR210HG-BPIFC Regulating the Progression of Hypertrophic Cardiomyopathy. (PMID:38474063)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusBpifcENSMUSG00000050108
rattus_norvegicusBpifcENSRNOG00000022937

Paralogs (12): BPIFB2 (ENSG00000078898), CETP (ENSG00000087237), PLTP (ENSG00000100979), BPI (ENSG00000101425), BPIFB1 (ENSG00000125999), LBP (ENSG00000129988), BPIFA2 (ENSG00000131050), BPIFA3 (ENSG00000131059), BPIFB6 (ENSG00000167104), BPIFB3 (ENSG00000186190), BPIFB4 (ENSG00000186191), BPIFA1 (ENSG00000198183)

Protein

Protein identifiers

BPI fold-containing family C proteinQ8NFQ6 (reviewed: Q8NFQ6)

Alternative names: Bactericidal/permeability-increasing protein-like 2

All UniProt accessions (3): Q8NFQ6, A0A8C8NLL8, Q5TI88

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Secreted.

Tissue specificity. Detected in the basal layer of the epidermis from inflammatory skin from psoriasis patients, but not in normal skin.

Similarity. Belongs to the BPI/LBP/Plunc superfamily. BPI/LBP family.

Isoforms (2)

UniProt IDNamesCanonical?
Q8NFQ6-11yes
Q8NFQ6-22

RefSeq proteins (1): NP_777592* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001124Lipid-bd_serum_glycop_CDomain
IPR017942Lipid-bd_serum_glycop_NDomain
IPR017943Bactericidal_perm-incr_a/b_domHomologous_superfamily
IPR017954Lipid-bd_serum_glycop_CSConserved_site
IPR030675BPI/LBPFamily
IPR032942BPI/LBP/PluncFamily

Pfam: PF01273, PF02886

UniProt features (19 total): glycosylation site 10, sequence variant 4, splice variant 2, signal peptide 1, chain 1, disulfide bond 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8NFQ6-F182.600.51

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Disulfide bonds (1): 161–200

Glycosylation sites (10): 372, 415, 79, 92, 113, 213, 225, 257, 301, 355

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 37 (showing top): GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOMF_LIPOPOLYSACCHARIDE_BINDING, GOMF_LIPID_BINDING, GOMF_PHOSPHOLIPID_BINDING, MIKKELSEN_MCV6_LCP_WITH_H3K27ME3, CHYLA_CBFA2T3_TARGETS_UP, LHX9_TARGET_GENES, MIR570_3P, MIR5688, MIR495_3P, MIR4755_5P, MIR5006_3P, MIR513B_5P, MIR6783_3P

GO Biological Process (4): innate immune response (GO:0045087), immune system process (GO:0002376), defense response to bacterium (GO:0042742), defense response to Gram-negative bacterium (GO:0050829)

GO Molecular Function (3): lipopolysaccharide binding (GO:0001530), phospholipid binding (GO:0005543), lipid binding (GO:0008289)

GO Cellular Component (2): obsolete extracellular space (GO:0005615), extracellular region (GO:0005576)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
lipid binding2
immune response1
defense response to symbiont1
biological_process1
defense response1
response to bacterium1
defense response to bacterium1
carbohydrate derivative binding1
binding1
cellular anatomical structure1

Protein interactions and networks

STRING

334 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
BPIFCTMEM239Q8WW34591
BPIFCWFDC12Q8WWY7498
BPIFCDEFB115Q30KQ5492
BPIFCDRC10Q96DY2478
BPIFCDEFB128Q7Z7B8471
BPIFCPGLYRP3Q96LB9428
BPIFCBPIFA1Q9NP55410
BPIFCCALHM4Q5JW98400
BPIFCFHIP2BQ86V87385
BPIFCPLEKHA4Q9H4M7383
BPIFCRFPL3O75679370
BPIFCINKA1Q96EL1354
BPIFCBPIFA2Q96DR5350
BPIFCRFPL2O75678349
BPIFCBPIFB1Q8TDL5343

IntAct

4 interactions, top by confidence:

ABTypeScore
BPIFCMETTL21Cpsi-mi:“MI:0915”(physical association)0.400
BPIFCHSPA2psi-mi:“MI:0915”(physical association)0.400
POLRMTpsi-mi:“MI:0914”(association)0.350

BioGRID (2): METTL21C (Affinity Capture-MS), HSPA2 (Affinity Capture-MS)

ESM2 similar proteins: A0A481NSZ4, A0JPN3, A2BGH0, A6QP57, D4A5U3, G3HIK4, O02668, O76879, P11597, P17213, P17453, P17454, P18428, P19823, P19827, P22687, P47896, P55058, P55065, P59826, P59827, P97278, Q05701, Q05704, Q08188, Q08189, Q0VCM5, Q10011, Q24764, Q28739, Q29052, Q2TBI0, Q61114, Q61702, Q61703, Q61805, Q63313, Q67E05, Q6AXU0, Q80ZU7

Diamond homologs: A0A481NSZ4, P17213, P17453, P18428, Q28739, Q2TBI0, Q61805, Q63313, Q8NFQ6, Q8C186

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

76 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance65
Likely benign3
Benign3

Top pathogenic / likely-pathogenic (0)

SpliceAI

1792 predictions. Top by Δscore:

VariantEffectΔscore
22:32417147:ACCTA:Aacceptor_loss1.0000
22:32417148:CCTAA:Cacceptor_loss1.0000
22:32417149:C:CAacceptor_loss1.0000
22:32417149:C:CCacceptor_gain1.0000
22:32417150:T:Aacceptor_loss1.0000
22:32432371:A:ACdonor_gain1.0000
22:32432372:C:CTdonor_gain1.0000
22:32432549:C:CTacceptor_gain1.0000
22:32432549:C:Tacceptor_gain1.0000
22:32432552:A:Cacceptor_gain1.0000
22:32432556:C:CTacceptor_gain1.0000
22:32432556:C:Tacceptor_gain1.0000
22:32432557:G:Tacceptor_gain1.0000
22:32435877:CACC:Cacceptor_gain1.0000
22:32435879:CC:Cacceptor_gain1.0000
22:32435880:CCTG:Cacceptor_gain1.0000
22:32437847:TAAAA:Tacceptor_gain1.0000
22:32437852:C:CCacceptor_gain1.0000
22:32437862:A:Tacceptor_gain1.0000
22:32447210:A:ACdonor_gain1.0000
22:32447211:C:CCdonor_gain1.0000
22:32453381:A:ACdonor_gain1.0000
22:32453382:C:CCdonor_gain1.0000
22:32453500:ACAC:Aacceptor_gain1.0000
22:32453501:CAC:Cacceptor_gain1.0000
22:32453501:CACC:Cacceptor_gain1.0000
22:32453502:AC:Aacceptor_gain1.0000
22:32453502:ACCT:Aacceptor_loss1.0000
22:32453503:CC:Cacceptor_gain1.0000
22:32453503:CCTG:Cacceptor_loss1.0000

AlphaMissense

3333 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
22:32432437:G:TA362D0.966
22:32432449:A:GL358P0.964
22:32432435:A:GS363P0.960
22:32431366:A:GC400R0.955
22:32431410:G:TA385D0.953
22:32431398:A:TV389D0.950
22:32432438:C:GA362P0.947
22:32419401:G:CF407L0.927
22:32419401:G:TF407L0.927
22:32419403:A:GF407L0.927
22:32445973:A:GL133P0.926
22:32417090:G:TA440D0.923
22:32435743:G:CF295L0.922
22:32435743:G:TF295L0.922
22:32435745:A:GF295L0.922
22:32435880:C:GG250R0.922
22:32447234:A:GW118R0.919
22:32447234:A:TW118R0.919
22:32419402:A:GF407S0.917
22:32431411:C:GA385P0.915
22:32447252:C:GA112P0.915
22:32442727:C:GC200S0.914
22:32442728:A:TC200S0.914
22:32414418:A:GL470P0.909
22:32435763:A:GS289P0.907
22:32431359:A:GL402S0.900
22:32435750:G:TA293D0.898
22:32435759:G:TA290E0.898
22:32442728:A:GC200R0.898
22:32432449:A:CL358R0.895

dbSNP variants (sampled 300 via entrez): RS1000126898 (22:32454912 G>T), RS1000129456 (22:32437909 T>C), RS1000156191 (22:32433194 C>A,G), RS1000180088 (22:32416834 C>A,G), RS1000183670 (22:32438285 A>T), RS1000232617 (22:32417169 G>A,C), RS1000388931 (22:32419195 T>C), RS1000426214 (22:32444245 G>T), RS1000508269 (22:32454326 A>G), RS1000614540 (22:32459807 T>A,C), RS1000790726 (22:32432752 G>A,T), RS1000844502 (22:32464914 C>T), RS1000881881 (22:32443943 A>G), RS1000897198 (22:32460776 G>A,T), RS1000961418 (22:32454053 G>A,C)

Disease associations

OMIM: gene MIM:614109 | disease phenotypes:

GenCC curated gene-disease

DiseaseClassificationInheritance
trichilemmal cystLimitedAutosomal dominant

Mondo (1): trichilemmal cyst (MONDO:0012328)

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST010002_81Refractive error6.000000e-13

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

8 total (human), top 8 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenateincreases abundance, decreases expression1
hydroquinoneincreases expression1
abrineincreases expression1
Arsenicdecreases expression, increases abundance1
Benzo(a)pyreneaffects methylation1
Tetrachlorodibenzodioxinincreases expression1
Lactic Aciddecreases expression1
Particulate Matterincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Associated diseases: trichilemmal cyst
  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): trichilemmal cyst